HealthNow rides fundraise wave into choppy US waters

HealthNow founder Steven Zinsli said the company “will go, and will win” in the competitive US healthcare market. (Image: HealthNow)

Ben Moore

Wed, 18 Jan 2023

HealthNow, an Auckland fintech for health services startup, will soon take on the challenging United States market through its subsidiary CoverUS.The company, which offers flexible healthcare payment options for customers and businesses, bought CoverUS in May last year. A prescription discount provider, CoverUS was partnered with 62,000 pharmacies across the US.While some of HealthNow's products were soft-launched in recent months, chief executive Steven Zinsli was jetting over to the US this week to prepare for an official launch in early...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Stay informed on business, government and financial developments across New Zealand.
Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Markets Market Close

NZ sharemarket dips as interest rates cut

The S&P/NZX 50 Index closed at 13,033.36, down 17.76 points or 0.14%.

Staff reporters 6:30pm

Economy

RBNZ plans more cuts sooner rather than later

The forecasts show the low at 3.1% by December this year.

Rebecca Howard 2:30pm

RBNZ plans more cuts sooner rather than later

Economy

RBNZ eases by 50bps and brings forward planned rate cuts

It now expects the cash rate to reach 3.1% in December.

Rebecca Howard 2:00pm

RBNZ eases by 50bps and brings forward planned rate cuts

Sponsored

Study NZ’s top MBA – on your terms

A world-class master's that fits around work and family life.

University of Aukland Business School

Sponsored

Investing in US technology: Navigating a high-speed sector

A new exchange-traded fund gives Kiwis access to US tech giants.

Smart Invest

More Health

Health

Compass calls Pita Pit, pie shop to the rescue

Nutritionists are not impressed.

Cécile Meier 13 Feb 2025

Law & Regulation

Class action targets ‘ineffective’ cold medicines

A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not work.Australia-based JGA Saddler filed a class action against Johnson & Johnson NZ on Thursday over its phenylephrine-based cold medicines tablets and syrups...

Staff reporters 13 Feb 2025